Exact Mass: 349.2344

Exact Mass Matches: 349.2344

Found 68 metabolites which its exact mass value is equals to given mass value 349.2344, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

AMD-070

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist > C107589 - CXCR4 Inhibitor

   

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


   

Abiraterone

2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,13-dien-5-ol

C24H31NO (349.2406)


   

Dipipanone

4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one

C24H31NO (349.2406)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

Vernakalant

1-[2-[2-(3,4-Dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol

C20H31NO4 (349.2253)


   

Acetyllycoclavine

Acetyllycoclavine

C20H31NO4 (349.2253)


   
   

Acetylfawcettiine

beta-Lofoline acetate

C20H31NO4 (349.2253)


   
   

tricalysiamide D

tricalysiamide D

C20H31NO4 (349.2253)


   

Reutericyclin

Reutericyclin

C20H31NO4 (349.2253)


   

(-)-lepadin C|(2S,3S,4aS,5S,8aR)-2-methyl-5-[(1E,3E)-7-oxo-1,3-octadienyl]decahydro-3-quinolinyl hydroxyacetate|lepadin C

(-)-lepadin C|(2S,3S,4aS,5S,8aR)-2-methyl-5-[(1E,3E)-7-oxo-1,3-octadienyl]decahydro-3-quinolinyl hydroxyacetate|lepadin C

C20H31NO4 (349.2253)


   

4-dihydroconsabatine

4-dihydroconsabatine

C20H31NO4 (349.2253)


   

Abiraterone

Abiraterone (CB-7598)

C24H31NO (349.2406)


A 3beta-sterol that is androsta-5,16-dien-3beta-ol substituted at position 17 by a 3-pyridyl group. Administered as the O-acetate, it is used for treatment of metastatic castrate-resistant prostate cancer. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02B - Hormone antagonists and related agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C147923 - CYP17A1 Inhibitor

   

dipipanone

dipipanone

C24H31NO (349.2406)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

JWH018 adamantyl

1-pentyl-3-(1-adamantoyl)indole

C24H31NO (349.2406)


   

N,N-Dimethyl-N-octyl-1-octanaminium bromide

N,N-Dimethyl-N-octyl-1-octanaminium bromide

C18H40BrN (349.2344)


   

Vernakalant

Vernakalant

C20H31NO4 (349.2253)


C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent C93038 - Cation Channel Blocker

   

2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL) PYRIDINE-4-BORONIC ACID PINACOL ESTER

2-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL) PYRIDINE-4-BORONIC ACID PINACOL ESTER

C18H32BNO3Si (349.2244)


   

3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

3-(((TERT-BUTYLDIMETHYLSILYL)OXY)METHYL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C18H32BNO3Si (349.2244)


   

2-Nitrophenyl myristate

2-Nitrophenyl myristate

C20H31NO4 (349.2253)


   

Aluminum magnesium isopropoxide

Aluminum magnesium isopropoxide

C15H38AlMgO5 (349.2385)


   

6-([(tert-Butyldimethylsilyl)oxy]methyl)pyridine-3-boronic acid pinacol ester

6-([(tert-Butyldimethylsilyl)oxy]methyl)pyridine-3-boronic acid pinacol ester

C18H32BNO3Si (349.2244)


   

Tetradecyldimethylethylammonium bromide

Tetradecyldimethylethylammonium bromide

C18H40BrN (349.2344)


   

4-Nitrophenyl myristate

4-Nitrophenyl myristate

C20H31NO4 (349.2253)


   

N-(1H-benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

N-(1H-benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine

C21H27N5 (349.2266)


   

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

1-Azabicyclo[2.2.2]octan-3-yl-bis(3,4-dimethylphenyl)methanol

C24H31NO (349.2406)


   

carbocyclic thromboxane A2(1-)

carbocyclic thromboxane A2(1-)

C21H33O4- (349.2379)


   

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-8-(dimethylamino)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one

C19H31N3O3 (349.2365)


   

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

(3S,8R,9R,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol

C24H31NO (349.2406)


   

NA-Taurine 15:0

NA-Taurine 15:0

C17H35NO4S (349.2287)


   
   

ST 18:1;O2;Gly

ST 18:1;O2;Gly

C20H31NO4 (349.2253)


   

Reutericyclin

Reutericyclin

C20H31NO4 (349.2253)


Reutericyclin (Reutericycline), a unique tetramic acid, is an antibiotic produced by some strains of Lactobacillus reuteri. Reutericyclin (Reutericycline) exhibits a broad inhibitory spectrum including Lactobacillus spp., Bacillus subtilis, B. cereus, Enterococcus faecalis, Staphylococcus aureus, and Listeria innocua[1][2].

   

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

(1r,2r,10s,11s,12s,13r,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-12-yl acetate

(1r,2r,10s,11s,12s,13r,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-12-yl acetate

C20H31NO4 (349.2253)


   

(5S,6S,15R)-15-Methyllycopodane-5,6-diol 5,6-diacetate

NA

C20H31NO4 (349.2253)


{"Ingredient_id": "HBIN011943","Ingredient_name": "(5S,6S,15R)-15-Methyllycopodane-5,6-diol 5,6-diacetate","Alias": "NA","Ingredient_formula": "C20H31NO4","Ingredient_Smile": "CC1CC2C3CCCN4C3(C1)C(CCC4)C(C2OC(=O)C)OC(=O)C","Ingredient_weight": "349.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "459","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21576176","DrugBank_id": "NA"}

   

acetylfawcettiine

NA

C20H31NO4 (349.2253)


{"Ingredient_id": "HBIN014474","Ingredient_name": "acetylfawcettiine","Alias": "NA","Ingredient_formula": "C20H31NO4","Ingredient_Smile": "CC1CC23C4CCCN2CCCC3C(CC4C1OC(=O)C)OC(=O)C","Ingredient_weight": "349.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38577","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101500246","DrugBank_id": "NA"}

   

n-{4-hydroxy-2-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

n-{4-hydroxy-2-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

C20H31NO4 (349.2253)


   

(1r,2r,10s,11r,13s,14r,15s)-14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

(1r,2r,10s,11r,13s,14r,15s)-14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

n-{2-hydroxy-5-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

n-{2-hydroxy-5-[(undecyloxy)carbonyl]phenyl}ethanimidic acid

C20H31NO4 (349.2253)


   

(1s,2r,10r,11r,13r,14s,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-14-yl acetate

(1s,2r,10r,11r,13r,14s,15r)-11-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-14-yl acetate

C20H31NO4 (349.2253)


   

2-methyl-5-(7-oxoocta-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

2-methyl-5-(7-oxoocta-1,3-dien-1-yl)-decahydroquinolin-3-yl 2-hydroxyacetate

C20H31NO4 (349.2253)


   

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-decahydronaphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

(2s)-1-{[(3r,3as,5ar,6r,9as,9bs)-6-hydroxy-5a-methyl-9-methylidene-decahydronaphtho[1,2-b]furan-3-yl]methyl}pyrrolidine-2-carboxylic acid

C20H31NO4 (349.2253)


   

5,6-dihydroxy-7-isopropyl-5,6-dimethyl-4-methylidene-3-oxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-1(15)-en-8-one

5,6-dihydroxy-7-isopropyl-5,6-dimethyl-4-methylidene-3-oxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-1(15)-en-8-one

C20H31NO4 (349.2253)


   

12-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

12-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

(1s,4s,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

(1s,4s,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)


   

n-(4-hydroxy-2-{[(9-methyldecyl)oxy]carbonyl}phenyl)ethanimidic acid

n-(4-hydroxy-2-{[(9-methyldecyl)oxy]carbonyl}phenyl)ethanimidic acid

C20H31NO4 (349.2253)


   

14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

14-(acetyloxy)-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-11-yl acetate

C20H31NO4 (349.2253)


   

3-acetyl-1-(dec-2-enoyl)-4-hydroxy-5-(2-methylpropyl)-5h-pyrrol-2-one

3-acetyl-1-(dec-2-enoyl)-4-hydroxy-5-(2-methylpropyl)-5h-pyrrol-2-one

C20H31NO4 (349.2253)


   

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-7-oxoocta-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-7-oxoocta-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate

C20H31NO4 (349.2253)


   

(1s,4r,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

(1s,4r,5r,9r,12r,13r,16r,17r)-17-(hydroxymethyl)-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-7-ene-7,9,17-triol

C20H31NO4 (349.2253)